Reckitt Benckiser has court win over misleading painkiller ads
Pharmaceutical giant Reckitt Benckiser has won a case alleging misleading conduct against New Zealand drug company AFT Pharmaceuticals over claims about pain relief tablets.
The dispute was over claims by AFT that its painkiller Maxigesic was more effective that Reckitt’s competing brand, Nuromol, made in marketing campaigns to promote Paracetamol-Ibuprofin combinations following the withdrawal of over-the-counter Codeine based medicines in February this year.
